Company Filing History:
Years Active: 1998
Title: Innovations by Joachim Eggert Roehr in Ocular Pressure Management
Introduction
Joachim Eggert Roehr is an accomplished inventor based in Somerset, NJ (US). He has made significant contributions to the field of ophthalmology, particularly in the management of intraocular pressure. His innovative work has led to the development of a unique ocular composition that addresses critical issues faced by glaucoma patients.
Latest Patents
Roehr holds a patent for "Synergistic intraocular pressure lowering combinations." This patent describes an ocular composition that includes an ocular decongestant, such as phenylephrine, combined with specific labdane derivatives that serve as intraocular pressure lowering agents. The composition not only effectively reduces ocular reddening caused by labdane compounds but also unexpectedly prolongs and enhances their intraocular pressure lowering effects. These advancements are particularly beneficial for treating glaucoma. Additionally, the patent outlines another ocular composition that incorporates para-aminoclonidine, an α2-adrenoreceptor agonist, which also reduces ocular reddening and lacrimation while potentiating the intraocular pressure lowering effect.
Career Highlights
Roehr's career has been marked by his dedication to research and innovation in the field of ocular health. He has worked with Hoechst Marion Roussel, where he has been able to apply his expertise to develop groundbreaking solutions for eye care. His work has not only contributed to scientific knowledge but has also had a direct impact on patient care.
Collaborations
Throughout his career, Roehr has collaborated with notable colleagues, including Paul Gary Conway and Grover C Helsley. These partnerships have fostered an environment of innovation and have led to the advancement of new ideas and technologies in the field.
Conclusion
Joachim Eggert Roehr's contributions to ocular pressure management through his innovative patents demonstrate his commitment to improving the lives of glaucoma patients. His work continues to influence the field of ophthalmology, showcasing the importance of research and collaboration in driving medical advancements.